In vitro activity of synthetic antimicrobial peptides against Candida.

Wojciech Kamysz, Piotr Nadolski, Anna Kedzia, Oscar Cirioni, Francesco Barchiesi, Andrea Giacometti, Giorgio Scalise, Jerzy Lukasiak, Marcin Okrój
Pol J Microbiol
2006; 55 (4):
ICID: 938525
Article type: Original article
IC™ Value: 9.00
Abstract provided by Publisher
 
Yeast-like fungi are the most common cause of fungal infections in humans. Actually, in the age of opportunistic infections and increasing resistance, development of modern antifungal agents becomes a very important challenge. This paper describes synthesis and antimicrobial assay of four naturally occurring peptide antibiotics (aurein 1.2, citropin 1.1, temporin A, uperin 3.6) and three chemically engineered analogues actually passing clinical trials (iseganan, pexiganan, omiganan) against Candida strains isolated from patients with infections of the oral cavity or respiratory tract. The peptides were synthesized using solid-phase method and purified by high-performance liquid chromatography. Biological tests were performed using the broth microdilution method. The antifungal activity of the peptide antibiotics was compared to that of nystatin and amphotericin B. We found synthetic peptides to be generally less potent than amphotericin B or nystatin. However, some of the naturally occurring peptides still retained reasonable antifungal activities which were higher than these of iseganan, pexiganan or omiganan. We think that the naturally occurring peptide antibiotics included in our study can be a good matrix for development of novel antifungal compounds.
PMID 17416067 - click here to show this article in PubMed
STATS


Related articles in IndexCopernicus™
     Respiratory Tract Infections - microbiology [120 related records]

Related articlesin PubMed database
  • in PubMed database [ related records]



  •